< 1 minute read
Jan. 17, 2022

Compound 24: a Brain-Penetrant, Type I LRRK2 Kinase Inhibitor

“compound 24”

LRRK2 kinase inhibitor preclinical, brain-penetrant from rational HTL and structure-guided opt. Journal of Medicinal Chemistry Merck & Co., Boston, MA

twitterlinkedinprintemail